TW200501987A - Ophthalmic solution preservatives - Google Patents
Ophthalmic solution preservativesInfo
- Publication number
- TW200501987A TW200501987A TW092134952A TW92134952A TW200501987A TW 200501987 A TW200501987 A TW 200501987A TW 092134952 A TW092134952 A TW 092134952A TW 92134952 A TW92134952 A TW 92134952A TW 200501987 A TW200501987 A TW 200501987A
- Authority
- TW
- Taiwan
- Prior art keywords
- ophthalmic solution
- accumulation
- shell
- amino acids
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Non-Alcoholic Beverages (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides an ophthalmic preservative having excellent antiseptic effect, low absorption/accumulation in the shell of the storing container and low stimulation for eyes. According to the present invention, the ophthalmic preservative prepared from the compolymer and its salts of the basic amino acids and hydroxyl-containing amino acids is characterized in that having excellent antiseptic effect, low absorption/ accumulation in the shell of the storing container.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002359415 | 2002-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200501987A true TW200501987A (en) | 2005-01-16 |
Family
ID=32500936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW092134952A TW200501987A (en) | 2002-12-11 | 2003-12-11 | Ophthalmic solution preservatives |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003289317A1 (en) |
TW (1) | TW200501987A (en) |
WO (1) | WO2004052403A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115315657A (en) * | 2020-03-26 | 2022-11-08 | 日油株式会社 | Inorganic microparticle adsorption inhibitor for soft contact lens |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2169084A1 (en) * | 1993-10-05 | 1995-04-13 | Manmohan Bhakoo | Improvements relating to antibacterial compositions |
JPH07218878A (en) * | 1994-02-08 | 1995-08-18 | Seiko Epson Corp | Solvent for contact lens |
JPH07223966A (en) * | 1994-02-08 | 1995-08-22 | Seiko Epson Corp | Artificial lacrima for ophthalmology |
ZA965367B (en) * | 1995-07-12 | 1997-01-23 | Novo Nordisk As | A pharmaceutical formulation |
JPH10203960A (en) * | 1997-01-24 | 1998-08-04 | Ofutekusu:Kk | Eye lotion composition |
AU2225701A (en) * | 1999-12-27 | 2001-07-09 | Santen Pharmaceutical Co. Ltd. | System for stabilizing lacrimal fluid layer |
JP3677421B2 (en) * | 1999-12-27 | 2005-08-03 | 扶桑薬品工業株式会社 | Composition for promoting lacrimal secretion |
JP2001228444A (en) * | 2000-02-18 | 2001-08-24 | Chisso Corp | Cleaning and disinfecting solution for contact lens |
JP2001261552A (en) * | 2000-03-22 | 2001-09-26 | Chisso Corp | Preserving agent for ophthalmic solution |
JP2001318350A (en) * | 2000-05-11 | 2001-11-16 | Lion Corp | Solution for contact lens |
WO2001098362A2 (en) * | 2000-06-16 | 2001-12-27 | Hercules Incorporated | Chemically-modified antimicrobial peptides, compositions and methods of production and use |
EP1312380B1 (en) * | 2000-06-19 | 2006-05-03 | Santen Pharmaceutical Co., Ltd. | Aseptics |
JP2002020320A (en) * | 2000-06-30 | 2002-01-23 | Santen Pharmaceut Co Ltd | Antiseptic agent for eye drop |
JP4099624B2 (en) * | 2001-04-24 | 2008-06-11 | ライオン株式会社 | Composition for soft contact lenses |
-
2003
- 2003-12-11 TW TW092134952A patent/TW200501987A/en unknown
- 2003-12-11 AU AU2003289317A patent/AU2003289317A1/en not_active Abandoned
- 2003-12-11 WO PCT/JP2003/015831 patent/WO2004052403A1/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115315657A (en) * | 2020-03-26 | 2022-11-08 | 日油株式会社 | Inorganic microparticle adsorption inhibitor for soft contact lens |
Also Published As
Publication number | Publication date |
---|---|
AU2003289317A1 (en) | 2004-06-30 |
WO2004052403A1 (en) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001094381A3 (en) | Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses | |
WO2003068128A3 (en) | Massage appliance comprising a storage container and a setting mechanism for setting a characteristic massage value | |
DE602004001692D1 (en) | "No-mix" multimineral hair decongestants | |
WO2005039291A3 (en) | Methods, compositions and devices for inducing stasis in cells | |
IL162838A (en) | Use of compounds modulating an atp-dependent enzymatic activity in compositions for prevention and treatment of amyloid-beta peptide-related disorders | |
EP1466912A4 (en) | 2-acylaminothiazole derivative or salt thereof | |
EP2740464A3 (en) | Antiperspirant active compositions having SEC chromatogram exhibiting high SEC peak 4 intensity | |
WO2004066899A3 (en) | System and method for face and body treatment | |
DE602004005188D1 (en) | SKIN COMPOSITIONS WITH AN OXIDOREDUCETASE ENZYME | |
AP2005003227A0 (en) | Synergistic combination of an alpha-2-delta ligandand a PDEV inhibitor for use in the treatment of pain. | |
TW200501987A (en) | Ophthalmic solution preservatives | |
AU2003227944A1 (en) | Ddah modulators in the treatment of pain | |
WO2004058282A3 (en) | Method of obtaining a soothing active ingredient, active ingredient and compositions obtained | |
HK1084029A1 (en) | Use of the distrontium salt of the acid 2-[n,n-di(carboxymethyl)amino]-3- cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain | |
WO2005007071A3 (en) | Skin formulation | |
WO2003007876A3 (en) | N-fatty acid-amino acid conjugates and therapeutic uses | |
DE50111407D1 (en) | MEDIUM CONTAINING N-CHLORTAURINE AND ITS USE FOR THE TREATMENT OF TREATMENT POLYPES | |
WO2004078927A3 (en) | Progenitor cells and methods of using same | |
MXPA05006408A (en) | Deuterated catecholamine derivatives and medicaments comprising said compounds. | |
HK1111924A1 (en) | Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient | |
MY144204A (en) | Aquoues olanexidine solution, method of preparing the same, and disinfectant | |
WO2005011737A3 (en) | Pharmaceutical combinations and formulations with improved stability | |
WO2007002780A3 (en) | Topical preservative compositions | |
WO2008145855A8 (en) | Pharmaceutical and/or cosmetic composition containing a cytochrome c-activating active ingredient | |
WO2005041854A3 (en) | Composition for the cosmetic treatment of age-related dermatological symptoms |